ECSP11010818A - Métodos para administrar formulaciones antifúngicas tópicas para el tratamiento de infecciones fúngicas - Google Patents

Métodos para administrar formulaciones antifúngicas tópicas para el tratamiento de infecciones fúngicas

Info

Publication number
ECSP11010818A
ECSP11010818A EC2011010818A ECSP11010818A ECSP11010818A EC SP11010818 A ECSP11010818 A EC SP11010818A EC 2011010818 A EC2011010818 A EC 2011010818A EC SP11010818 A ECSP11010818 A EC SP11010818A EC SP11010818 A ECSP11010818 A EC SP11010818A
Authority
EC
Ecuador
Prior art keywords
treatment
formulations
antifungical
administer
topic
Prior art date
Application number
EC2011010818A
Other languages
English (en)
Inventor
Gregor Cevc
Ulrich Vierl
Original Assignee
Targeted Delivery Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targeted Delivery Technologies Ltd filed Critical Targeted Delivery Technologies Ltd
Publication of ECSP11010818A publication Critical patent/ECSP11010818A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se relaciona con formulaciones tópicas de un antifúngico que comprende uno o más antifúngicos, un lípido y un tensoactivo, y usos de los mismos para el tratamiento de infecciones fúngicas de la piel y las uñas.
EC2011010818A 2008-07-23 2011-02-10 Métodos para administrar formulaciones antifúngicas tópicas para el tratamiento de infecciones fúngicas ECSP11010818A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8311508P 2008-07-23 2008-07-23
US10211108P 2008-10-02 2008-10-02
US15018709P 2009-02-05 2009-02-05
US16812209P 2009-04-09 2009-04-09

Publications (1)

Publication Number Publication Date
ECSP11010818A true ECSP11010818A (es) 2011-05-31

Family

ID=41358304

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2011010818A ECSP11010818A (es) 2008-07-23 2011-02-10 Métodos para administrar formulaciones antifúngicas tópicas para el tratamiento de infecciones fúngicas

Country Status (15)

Country Link
US (2) US20100086504A1 (es)
EP (1) EP2317993A2 (es)
JP (1) JP2011529038A (es)
KR (1) KR20110039357A (es)
CN (1) CN102159202A (es)
AU (1) AU2009275230A1 (es)
CA (1) CA2731455A1 (es)
CL (1) CL2011000135A1 (es)
CO (1) CO6351719A2 (es)
EC (1) ECSP11010818A (es)
IL (1) IL210813A0 (es)
MX (1) MX2011000932A (es)
NI (1) NI201100025A (es)
PE (1) PE20110642A1 (es)
WO (1) WO2010010470A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008097530A1 (en) 2007-02-05 2008-08-14 Biophile Corporation, Ltd Increased effectiveness of allylamine drug compounds
BRPI0924302A2 (pt) * 2009-02-05 2019-09-24 Targeted Delivery Tech Limited métodos de reduzir a proliferação e a viabilidade de agentes microbianos
FR2954163B1 (fr) * 2009-12-18 2012-03-16 Galderma Pharma Sa Utilisation d'un tensioactif cationique, avantageu-sement amphotere, pour la preparation d'une composition antifongique applicable sur l'ongle
WO2011079234A2 (en) 2009-12-23 2011-06-30 Nuvo Research Inc. Highly permeating terbinafine formulation
EP2672962B1 (en) 2011-02-11 2015-03-25 Moberg Pharma AB Novel antifungal composition
DE112012001386T5 (de) * 2011-03-21 2013-12-19 Gregor Cevc Optimierte Präparate von sehr anpassungsfähigen Aggregaten
WO2013057208A1 (en) 2011-10-18 2013-04-25 Targeted Delivery Technologies Limited Compositions and methods for reducing the proliferation and viability of microbial agents
US8697753B1 (en) * 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EP3116986B1 (en) 2014-03-14 2023-07-05 GOJO Industries, Inc. Hand sanitizers with improved aesthetics and skin-conditioning to encourage compliance with hand hygiene guidelines
AT516544B1 (de) 2014-12-02 2017-05-15 Universität Innsbruck Stoffgemisch und Zubereitung
CN105193726B (zh) * 2015-11-08 2018-01-26 长沙佰顺生物科技有限公司 一种治疗灰指甲的药物组合物
KR101952715B1 (ko) * 2017-09-27 2019-02-27 경희대학교 산학협력단 천연 화합물을 포함하는 칸디다증 개선용 항진균 조성물
RU2698454C1 (ru) * 2018-11-12 2019-08-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КубГМУ Минздрава России) Способ лечения онихомикозов стоп
KR102072946B1 (ko) 2019-08-06 2020-02-03 주식회사 씨엔엘바이오텍 조갑진균증 예방 또는 치료용 조성물
CA3157201A1 (en) * 2019-10-08 2021-04-15 Hallux Inc. Onychomycosis treatment compositions and methods
AT524378A1 (de) 2020-11-06 2022-05-15 Univ Innsbruck Zubereitung
IL303476A (en) * 2020-12-08 2023-08-01 Moberg Pharma Ab Nail fungus treatment regimen using allylamine antifungal preparations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE10272T1 (de) * 1979-08-22 1984-11-15 Sandoz Ag Propenylamine, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und ihre verwendung als arzneimittel.
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
ATE267613T1 (de) * 1998-03-05 2004-06-15 Phares Pharm Res Nv Arzneimittel und deren verwendung
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
US6846837B2 (en) * 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails
US20040105881A1 (en) 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
AP2006003784A0 (en) * 2004-03-18 2006-10-31 Panacea Biotec Ltd Novel compositions for topical delivery
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
WO2006103638A2 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
US20070077283A1 (en) * 2005-09-30 2007-04-05 Nastech Pharmaceutical Company Inc. Method of enhancing transmucosal delivery of therapeutic compounds
JP5467722B2 (ja) * 2007-01-16 2014-04-09 ロート製薬株式会社 皮膚外用乳化製剤
WO2008097530A1 (en) * 2007-02-05 2008-08-14 Biophile Corporation, Ltd Increased effectiveness of allylamine drug compounds

Also Published As

Publication number Publication date
EP2317993A2 (en) 2011-05-11
KR20110039357A (ko) 2011-04-15
US7820720B2 (en) 2010-10-26
MX2011000932A (es) 2011-05-19
AU2009275230A1 (en) 2010-01-28
WO2010010470A3 (en) 2010-03-18
CL2011000135A1 (es) 2011-09-23
PE20110642A1 (es) 2011-08-31
US20100086504A1 (en) 2010-04-08
CA2731455A1 (en) 2010-01-28
CN102159202A (zh) 2011-08-17
NI201100025A (es) 2011-11-02
CO6351719A2 (es) 2011-12-20
WO2010010470A2 (en) 2010-01-28
JP2011529038A (ja) 2011-12-01
US20100104633A1 (en) 2010-04-29
IL210813A0 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
ECSP11010818A (es) Métodos para administrar formulaciones antifúngicas tópicas para el tratamiento de infecciones fúngicas
CL2014003225A1 (es) Composición que comprende un agente de control biológico y un fungicida.
CO6602146A2 (es) Uso combinado de proteínas cryda y cry1fa para el manejo de la resistencia de los insectos
NI201100152A (es) Métodos para reducir la proliferación y viabilidad de los agentes microbianos
PE20150200A1 (es) Formulacion de anticuerpos
CR20160222U (es) Formas solidas de acido { [ -(3- clorofenil) -3- hidroxipiridin -2-carbonil] amino} acetico, composiciones, y usos de las mismas
AR087838A1 (es) Composiciones parasiticidas que comprenden un agente activo de isoxazolina, sus metodos y usos
AR075442A1 (es) Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
CR20140318A (es) Composiciones intranasales de dexmedetomidina y métodos de uso de ellas
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
CO6460708A2 (es) Composiciones borínicas
BR112017011440A2 (pt) uma composição antimicrobiana
CL2011002675A1 (es) Uso de compuestos derivados de nitrato o sulfato de 9-purin-9-il-3,4-dihidroxitetrahidrofuran-2-il-metilo para reducir la presion intraocular ; composicion farmaceutica oftalmica que comprende los compuestos; y formulacion oftalmica de uso topico que los comprende.
CL2008002242A1 (es) Compuestos derivados de n-cicloalquil-n-carboxamida, tiocarboxamida, biciclicas o derivados de carboximidamida n-sustituida; composicion fungicida; y metodo para controlar los hongos fitopatogenos de los cultivos.
BR112016006048A8 (pt) composições antimicrobianas
AR097599A1 (es) Una composición que comprende extracto de guaçatonga y aroeira, su uso y un método para la prevención y/o tratamiento de señales causadas por el envejecimiento de la piel
CO7250444A2 (es) Uso de seaprose para eliminar biopelículas bacterianas
AR083126A1 (es) Composicion vacunal para el control de las infestaciones por ectoparasitos
BR112014001825A2 (pt) lenço para a aplicação de pelo menos um princípio ativo sobre a pele
AR087790A1 (es) Uso de un inhibidor de aromatasa para el tratamiento de hipogonadismo y enfermedades relacionadas
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
CO7151497A2 (es) Composiciones parasiticidas que comprenden derivados de benzimidazol, métodos y usos de los mismos
CL2012001757A1 (es) Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica; y su uso en el tratamiento de infecciones micoticas.
CL2015002191A1 (es) Composición antifúngica tópica para el tratamiento de onicomicosis.
ECSP15003613A (es) Formulación transdérmica que contiene inhibidores de cox